234 related articles for article (PubMed ID: 35633317)
1. AUP1 regulates lipid metabolism and induces lipid accumulation to accelerate the progression of renal clear cell carcinoma.
Chen C; Zhao W; Lu X; Ma Y; Zhang P; Wang Z; Cui Z; Xia Q
Cancer Sci; 2022 Aug; 113(8):2600-2615. PubMed ID: 35633317
[TBL] [Abstract][Full Text] [Related]
2. E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesis.
Shen D; Gao Y; Huang Q; Xuan Y; Yao Y; Gu L; Huang Y; Zhang Y; Li P; Fan Y; Tang L; Du S; Wu S; Wang H; Wang C; Gong H; Pang Y; Ma X; Wang B; Zhang X
Cancer Lett; 2021 Aug; 514():48-62. PubMed ID: 34019961
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma.
Zhao L; Wang Z; Xu Y; Zhang P; Qiu J; Nie D; Wu G; Chen C; Chang Y; Xia Q
Pathol Res Pract; 2023 Aug; 248():154641. PubMed ID: 37467634
[TBL] [Abstract][Full Text] [Related]
4. The ménage à trois of autophagy, lipid droplets and liver disease.
Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the AMPK-GATA3-ECHS1 Pathway Induces Fatty Acid Synthesis That Promotes Clear Cell Renal Cell Carcinoma Growth.
Qu YY; Zhao R; Zhang HL; Zhou Q; Xu FJ; Zhang X; Xu WH; Shao N; Zhou SX; Dai B; Zhu Y; Shi GH; Shen YJ; Zhu YP; Han CT; Chang K; Lin Y; Zang WD; Xu W; Ye DW; Zhao SM; Zhao JY
Cancer Res; 2020 Jan; 80(2):319-333. PubMed ID: 31690668
[TBL] [Abstract][Full Text] [Related]
6. Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
Wu G; Wang Q; Xu Y; Li J; Zhang H; Qi G; Xia Q
Cell Death Dis; 2019 May; 10(6):416. PubMed ID: 31138790
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets.
Tan SK; Hougen HY; Merchan JR; Gonzalgo ML; Welford SM
Nat Rev Urol; 2023 Jan; 20(1):48-60. PubMed ID: 36192502
[TBL] [Abstract][Full Text] [Related]
8. Bile Acid Metabolism Mediates Cholesterol Homeostasis and Promotes Tumorigenesis in Clear Cell Renal Cell Carcinoma.
Riscal R; Gardner SM; Coffey NJ; Carens M; Mesaros C; Xu JP; Xue Y; Davis L; Demczyszyn S; Vogt A; Olia A; Finan JM; Godfrey J; Schultz DC; Blair IA; Keith B; Marmorstein R; Skuli N; Simon MC
Cancer Res; 2024 May; 84(10):1570-1582. PubMed ID: 38417134
[TBL] [Abstract][Full Text] [Related]
9. HAO2 inhibits malignancy of clear cell renal cell carcinoma by promoting lipid catabolic process.
Xiao W; Wang X; Wang T; Chen B; Xing J
J Cell Physiol; 2019 Dec; 234(12):23005-23016. PubMed ID: 31127626
[TBL] [Abstract][Full Text] [Related]
10. FABP5 is correlated with poor prognosis and promotes tumour cell growth and metastasis in clear cell renal cell carcinoma.
Wu G; Xu Y; Wang Q; Li J; Li L; Han C; Xia Q
Eur J Pharmacol; 2019 Nov; 862():172637. PubMed ID: 31491402
[TBL] [Abstract][Full Text] [Related]
11. Fatty Acid Oxidation Mediated by Malonyl-CoA Decarboxylase Represses Renal Cell Carcinoma Progression.
Zhou L; Luo Y; Liu Y; Zeng Y; Tong J; Li M; Hou Y; Du K; Qi Y; Pan W; Liu Y; Wang R; Tian F; Gu C; Chen K
Cancer Res; 2023 Dec; 83(23):3920-3939. PubMed ID: 37729394
[TBL] [Abstract][Full Text] [Related]
12. GPX8 regulates clear cell renal cell carcinoma tumorigenesis through promoting lipogenesis by NNMT.
Nguyen TTM; Nguyen TH; Kim HS; Dao TTP; Moon Y; Seo M; Kang S; Mai VH; An YJ; Jung CR; Kim JM; Park S
J Exp Clin Cancer Res; 2023 Feb; 42(1):42. PubMed ID: 36750850
[TBL] [Abstract][Full Text] [Related]
13. MBOAT7-driven phosphatidylinositol remodeling promotes the progression of clear cell renal carcinoma.
Neumann CKA; Silver DJ; Venkateshwari V; Zhang R; Traughber CA; Przybycin C; Bayik D; Smith JD; Lathia JD; Rini BI; Brown JM
Mol Metab; 2020 Apr; 34():136-145. PubMed ID: 32180553
[TBL] [Abstract][Full Text] [Related]
14. TBC1D5 reverses the capability of HIF-2α in tumor progression and lipid metabolism in clear cell renal cell carcinoma by regulating the autophagy.
Huang Y; Xiong Z; Wang J; Gao Y; Cao Q; Wang D; Shi J; Chen Z; Yang X
J Transl Med; 2024 Feb; 22(1):212. PubMed ID: 38419050
[TBL] [Abstract][Full Text] [Related]
15. The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma.
Miess H; Dankworth B; Gouw AM; Rosenfeldt M; Schmitz W; Jiang M; Saunders B; Howell M; Downward J; Felsher DW; Peck B; Schulze A
Oncogene; 2018 Oct; 37(40):5435-5450. PubMed ID: 29872221
[TBL] [Abstract][Full Text] [Related]
16. CPT2-mediated fatty acid oxidation inhibits tumorigenesis and enhances sorafenib sensitivity via the ROS/PPARγ/NF-κB pathway in clear cell renal cell carcinoma.
Zeng K; Li Q; Song G; Chen B; Luo M; Miao J; Liu B
Cell Signal; 2023 Oct; 110():110838. PubMed ID: 37541641
[TBL] [Abstract][Full Text] [Related]
17. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell Carcinoma.
Riscal R; Bull CJ; Mesaros C; Finan JM; Carens M; Ho ES; Xu JP; Godfrey J; Brennan P; Johansson M; Purdue MP; Chanock SJ; Mariosa D; Timpson NJ; Vincent EE; Keith B; Blair IA; Skuli N; Simon MC
Cancer Discov; 2021 Dec; 11(12):3106-3125. PubMed ID: 34244212
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma.
Xu GH; Lou N; Shi HC; Xu YC; Ruan HL; Xiao W; Liu L; Li X; Xiao HB; Qiu B; Bao L; Yuan CF; Zhou YL; Hu WJ; Chen K; Yang HM; Zhang XP
BMC Cancer; 2018 Jan; 18(1):88. PubMed ID: 29357836
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal acid lipase promotes cholesterol ester metabolism and drives clear cell renal cell carcinoma progression.
Wang J; Tan M; Ge J; Zhang P; Zhong J; Tao L; Wang Q; Tong X; Qiu J
Cell Prolif; 2018 Aug; 51(4):e12452. PubMed ID: 29569766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
